Mission and Vision
BioPorto will constantly seek to select new diagnostic biomarker targets from the marketed antibody portfolio that have clinical relevance, potential for a large market in routine diagnostics and for patent protection and by this selection achieve as large a share of the routine diagnostic market as possible.
